BFM
GMAB icon

Boothbay Fund Management’s Genmab GMAB Stock Holding History

Boothbay Fund Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,048
Closed -$1.07M – 2394
2026
Q1 		$1.07M Buy
+40,048
New +$1.2M 0.01% 906
2025
Q4 		– Sell
-63,700
Closed -$1.95M – 2101
2025
Q3 		$1.95M Buy
+63,700
New +$1.55M 0.03% 576

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Boothbay Fund Management's GMAB Position: Q2 2026 in Review

Boothbay Fund Management sold out of Genmab (GMAB) in Q2 2026, closing a stake of 40,048 shares — an estimated $1.07M sold.

Boothbay Fund Management first reported a position in GMAB in Q3 2025 and held it in 2 quarters. The position peaked at $1.95M in Q3 2025. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Boothbay Fund Management reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 40,048 Genmab shares in Q2 2026, an estimated $1.07M.
  • Boothbay Fund Management first reported a position in Genmab in Q3 2025 and held it in 2 quarters.
  • Boothbay Fund Management's Genmab position peaked at $1.95M in Q3 2025.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.